Quanterix CorpQTRXEarnings & Financial Report
Quanterix Corp is a life sciences firm that develops, manufactures, and commercializes ultra-sensitive single-molecule detection diagnostic platforms, reagents, and testing services. Its solutions empower biological research, drug development, and clinical diagnostics across oncology, neurodegenerative disorders, infectious diseases, and other therapeutic areas, serving research institutions, biopharmaceutical companies, and clinical laboratories globally.
QTRX Q4 FY2025 Key Financial Metrics
Revenue
$43.9M
Gross Profit
$20.0M
Operating Profit
$-24.8M
Net Profit
$-23.1M
Gross Margin
45.7%
Operating Margin
-56.4%
Net Margin
-52.7%
YoY Growth
24.7%
EPS
$-0.48
Quanterix Corp Q4 FY2025 Financial Summary
Quanterix Corp reported revenue of $43.9M (up 24.7% YoY) for Q4 FY2025, with a net profit of $-23.1M (down 98.8% YoY) (-52.7% margin). Cost of goods sold was $23.8M, operating expenses totaled $44.8M.
Key Financial Metrics
| Total Revenue | $43.9M |
|---|---|
| Net Profit | $-23.1M |
| Gross Margin | 45.7% |
| Operating Margin | -56.4% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Quanterix Corp Q4 FY2025 revenue of $43.9M breaks down across 3 segments, led by Products at $29.2M (66.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $29.2M | 66.6% |
| Consumable And Other Products | $12.7M | 28.9% |
| Service Type Warranties | $1.7M | 3.8% |
Quanterix Corp Revenue by Segment — Quarterly Trend
Quanterix Corp revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Consumable And Other Products) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $29.2M | $26.2M | $16.8M | $20.7M |
| Consumable And Other Products | $12.7M | — | — | — |
| Service Type Warranties | $1.7M | — | $1.5M | $1.5M |
Quanterix Corp Annual Revenue by Year
Quanterix Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $138.9M).
Quanterix Corp Quarterly Revenue & Net Profit History
Quanterix Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $43.9M | +24.7% | $-23.1M | -52.7% |
| Q3 FY2025 | $40.2M | +12.3% | $-33.5M | -83.3% |
| Q2 FY2025 | $24.5M | -28.8% | $-30.0M | -122.6% |
| Q1 FY2025 | $30.3M | -5.4% | $-20.5M | -67.6% |
| Q4 FY2024 | $35.2M | +11.4% | $-11.6M | -33.1% |
| Q3 FY2024 | $35.8M | +13.5% | $-8.4M | -23.3% |
| Q2 FY2024 | $34.4M | +11.6% | $-7.4M | -21.5% |
| Q1 FY2024 | $32.1M | +12.7% | $-11.2M | -34.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.1M | $34.4M | $35.8M | $35.2M | $30.3M | $24.5M | $40.2M | $43.9M |
| YoY Growth | 12.7% | 11.6% | 13.5% | 11.4% | -5.4% | -28.8% | 12.3% | 24.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $414.2M | $415.9M | $411.0M | $406.5M | $396.5M | $375.6M | $444.1M | $418.8M |
| Liabilities | $70.8M | $75.1M | $72.1M | $76.5M | $80.1M | $83.2M | $129.6M | $123.0M |
| Equity | $343.4M | $340.8M | $338.9M | $330.0M | $316.4M | $292.5M | $314.5M | $295.7M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-20.2M | $-5.0M | $-5.7M | $-4.3M | $-13.9M | $-5.7M | $-41.2M | $-16.4M |